Results 101 to 110 of about 53,405 (189)

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD. [PDF]

Cell Transplant, 2022
Baek DW, Cho HJ, Kim JH, Ahn JS, Kim HJ, Lim SN, Cheong JW, Kim SY, Lee HS, Won JH, Yhim HY, Sohn SK, Moon JH.   +12 more
europepmc   +1 more source

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

Journal of Clinical Oncology, 2007
Haesun Choi, C. Charnsangavej, S. Faria, H. Macapinlac, M. Burgess, Shreyaskumar R Patel, Lei L Chen, D. Podoloff, R. Benjamin   +8 more
semanticscholar   +1 more source

Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia. [PDF]

Glob Med Genet
Donchev PP, Vasileva EY, Paunova-Krasteva TS, Danova ST.   +3 more
europepmc   +1 more source

Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML. [PDF]

Med Int (Lond), 2022
Yildirim MS, Şi̇mşek L, Zamani̇ AG, Çeneli̇ Ö, Demi̇rci̇oğlu S.   +4 more
europepmc   +1 more source

Nail lichen planus associated with imatinib mesylate. [PDF]

JAAD Case Rep
Axler E, Loesch E, Vaidya T, Neubauer Z, Lipner SR.   +4 more
europepmc   +1 more source

Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling. [PDF]

Biomedicines, 2021
Montella L, Ottaviano M, Riccio V, Picozzi F, Facchini G, Insabato L, Giuliano M, Palmieri G.   +7 more
europepmc   +1 more source

Successful treatment of metastatic dermatofibrosarcoma protuberans of the breast to the lungs with imatinib mesylate: a case report. [PDF]

Ecancermedicalscience
Kpatsi S, Daniels J, Kyei KA, Vanderpuye V.   +3 more
europepmc   +1 more source

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery. [PDF]

Int J Nanomedicine, 2021
Xu H, Ji H, Li Z, Qiao W, Wang C, Tang J.   +5 more
europepmc   +1 more source

Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients. [PDF]

ACS Omega
Mou Y, Zhao Y, Wen S, Li X, Zhang W, Xu X, Wang Y.   +6 more
europepmc   +1 more source

Multiple Eruptive Dermatofibromas Secondary to Imatinib Mesylate in a Patient with Chronic Myeloid Leukemia. [PDF]

Indian J Dermatol, 2021
Lira-Valero FJ, Godínez-Aldrete L, Pulido-Díaz N, Quintal-Ramírez MJ.   +3 more
europepmc   +1 more source